Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab to treat adults with bullous pemphigoid.

Morgantown’s Civilian Police Review and Advisory Board has set a review of the Morgantown Police Department’s officer-worn ...

Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...

Minister for Social Security and Disabilities, Sir Stephen Timms also reassured existing PIP claimants with an outstanding ...

Pharming has agreed a deal to sell a recently awarded priority review voucher (PRV) to Novartis for around $21 million - well below the market rate. The price of PRVs, which can be used to shorten ...

Neuren Pharmaceuticals was among the best-performing ASX 200 stocks in morning trade after securing a rare pediatric disease ...

Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million.

Higher education institutions are investing in sustainability initiatives, but their specific goals and challenges remain ...

RBI raises loan limits for urban cooperative banks, adjusts real estate exposure norms, and extends deadline for prudential ...

Health care worker safety is in the spotlight following recent events. Discover what experts say about preventing violence in ...

Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced that the U.S. Food and Drug ...